Kimia utilizes chemotype evolution to create extensive datasets that uncover molecular traits of active and inactive drugs. By automating and applying machine learning to target-specific datasets, the platform accelerates novel compound design, expediting drug discovery.
Founders
Chief Executive Officer
![](https://cdn.prod.website-files.com/643eb96c73d3a7f81ef48898/657cb8c19ef22ca38549b281_stig.jpg)
Stig Hansen
![](https://cdn.prod.website-files.com/643eb96c73d3a7f81ef48898/657cf49ed116f1873f8ba57c_image%204.jpg)
Jack Sadowsky
![](https://cdn.prod.website-files.com/643eb96c73d3a7f81ef48898/657cf4f901e08fcd615d2905_image%205.jpg)
Ray Fucini